<DOC>
	<DOCNO>NCT00770016</DOCNO>
	<brief_summary>The aim study characterize treatment related change insulin sensitivity , substrate metabolism intra hepatic- intramyocellular lipid content patient hypothyroidism</brief_summary>
	<brief_title>Insulin Sensitivity Metabolism Before After Treatment Patients With Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>write informed consent must legal age competent Age &gt; 18 year presently diagnose hypothyroidism alcohol consumption &gt; 21 unit per week Malignant disease pregnancy magnetic implant material body BMI &gt; 30 Heart disease ( NYHA &gt; 2 ) Uncontrolled hypertension Manifest diabetes mellitus Changes medication , influence glucose metabolism , 2 month prior end trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>insulin sensitivity</keyword>
	<keyword>Substrate metabolism</keyword>
	<keyword>Fatty liver</keyword>
	<keyword>intramyocellular lipid</keyword>
	<keyword>intracellular signal</keyword>
</DOC>